MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

TLRY

6.95

+0.43%↑

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

TLRY

6.95

+0.43%↑

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

TLRY

6.95

+0.43%↑

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

TLRY

6.95

+0.43%↑

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

TLRY

6.95

+0.43%↑

Search

Illumina Inc

Ouvert

SecteurSoins de santé

131.7 1.21

Résumé

Variation du prix de l'action

24h

Actuel

Min

129.31

Max

133.11

Chiffres clés

By Trading Economics

Revenu

184M

334M

Ventes

76M

1.2B

P/E

Moyenne du Secteur

23.439

66.418

Marge bénéficiaire

28.818

Employés

8,600

EBITDA

108M

445M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+7.38% upside

Dividendes

By Dow Jones

Prochains Résultats

30 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.2B

20B

Ouverture précédente

130.49

Clôture précédente

131.7

Sentiment de l'Actualité

By Acuity

11%

89%

12 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Illumina Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 avr. 2026, 23:36 UTC

Acquisitions, Fusions, Rachats

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion -- Update

14 avr. 2026, 23:24 UTC

Actions en Tendance

Stocks to Watch: Gloo, Broadcom, GitLab

14 avr. 2026, 22:42 UTC

Acquisitions, Fusions, Rachats

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion

14 avr. 2026, 21:32 UTC

Principaux Mouvements du Marché

GitLab Shares Rise on Expanded Google Cloud Collaboration

14 avr. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About Energy Shortage Ease -- Market Talk

14 avr. 2026, 23:34 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

14 avr. 2026, 22:54 UTC

Résultats

BRP: Amendment Mainly Leads to 25% Tariff on Total Value of Imported Snowmobiles and Majority of ORV Models, Replacing Previous 50% Tariff on Applicable Metal Content Only >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Suspending Guidance Following Amendment of Section 232 Tariffs on Steel, Aluminum and Copper Imports Into U.S., Which Came Into Effect on April 6 >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Currently Estimates Potential Incremental Tariff Cost Related to This Amendment in Excess of $500M for Remainder of Yr >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Suspends FY27 Guidance Due to Changes to U.S. Tariff Environment

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Targets Deal Completion Toward End of 3Q

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Acquisition Diversifies Portfolio; Met Coal Share to Rise to 22%

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Asset 'Strong Strategic Fit'; to Positively Add Production, Cash Flow

14 avr. 2026, 22:16 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Intends to Fund Acquisition With Cash, 5-Year Loan Facility

14 avr. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Contingent Consideration Linked to Average Annual Prices For 5 Years

14 avr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Deal Includes Contingent Cash Consideration Up to $550 Million

14 avr. 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Deal Includes $1.85 Billion Upfront Consideration

14 avr. 2026, 22:12 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: To Buy Kestrel Stake From EMR Capital, Adaro Capital

14 avr. 2026, 22:12 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: To Buy Kestrel Stake For Up to $2.4 Billion

14 avr. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: to Acquire 80% Interest in Kestrel Coal Mine

14 avr. 2026, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

14 avr. 2026, 20:33 UTC

Acquisitions, Fusions, Rachats

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 avr. 2026, 20:32 UTC

Actions en Tendance

Stocks to Watch: JPMorgan, American Airlines, LVMH, BlackRock -- WSJ

14 avr. 2026, 19:59 UTC

Acquisitions, Fusions, Rachats

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 avr. 2026, 19:38 UTC

Résultats

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 avr. 2026, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

14 avr. 2026, 19:21 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Retreat on Hopes for U.S.-Iran Peace Talks -- Market Talk

14 avr. 2026, 19:09 UTC

Acquisitions, Fusions, Rachats

Apple and Amazon Partner on Satellite Deal. Why It Makes Sense. -- Barrons.com

14 avr. 2026, 18:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 avr. 2026, 18:30 UTC

Market Talk

Treasury Yields, Dollar Fall as Markets Price Higher Odds of Fed Cuts -- Market Talk

Comparaison

Variation de prix

Illumina Inc prévision

Objectif de Prix

By TipRanks

7.38% hausse

Prévisions sur 12 Mois

Moyen 136.33 USD  7.38%

Haut 170 USD

Bas 85 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

11 ratings

4

Achat

5

Maintien

2

Vente

Score Technique

By Trading Central

77.61 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

12 / 348Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat